COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC:
Get the latest research information from NIH:

Coronavirus Guidance for NIH Applicants and Grantees:

Dr. Richard Ingraham

Dr. Richard Ingraham

Scientific Review Officer


Division of Translational and Clinical Sciences DTCS
Musculoskeletal, Oral and Skin Sciences MOSS
Study Section:
Skeletal Muscle and Exercise Physiology SMEP

Dr. Richard Ingraham is a Scientific Review Officer in the Musculoskeletal, Oral and Skin Sciences Integrated Review Group.

He received his Ph.D. degree in biochemistry at the University of Iowa. His graduate work focused on biophysical aspects of skeletal muscle regulatory proteins. His post-doctoral work was at the University of Alberta and involved examination of additional aspects of muscle regulation using peptide and protein chemistry approaches. He next joined Boehringer Ingelheim Pharmaceuticals, where he worked for many years on drug discovery projects ranging from virology (the AIDS drug Viramune) to inflammatory and autoimmune diseases before joining the Cardiovascular Disease Department to work on projects in atherosclerosis and hypertension. Dr. Ingraham has 30 research publications and is an inventor on 7 patents/patent applications. Prior to joining CSR, he was a visiting assistant professor of biochemistry at Quinnipiac University.